These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7482504)

  • 1. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.
    Filaci G; Contini P; Brenci S; Lanza L; Scudeletti M; Indiveri F; Puppo F
    Tissue Antigens; 1995 Aug; 46(2):117-23. PubMed ID: 7482504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Soluble HLA class I and HLA class II antigens in the blood of HIV infected patients].
    Khudiakova NE; Novikov VV; Kravchenko GA; Ivanova NI; Ptitsyna IuS; Nosov NN
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):42-5. PubMed ID: 15024980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples.
    Hausmann S; Claus R; Falk U; Wegener S
    J Immunoassay; 1996 Aug; 17(3):257-75. PubMed ID: 8842984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
    Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S
    Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection.
    Puppo F; Pellicci R; Brenci S; Nocera A; Morelli N; Dardano G; Bertocchi M; Antonucci A; Ghio M; Scudeletti M
    Hum Immunol; 1994 Jul; 40(3):166-70. PubMed ID: 7960957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis.
    Heiligenhaus A; Rebmann V; Neubert A; Plewa S; Ferencik S; Vögeler U; Steuhl KP; Grosse-Wilde H
    Tissue Antigens; 2004 Apr; 63(4):369-75. PubMed ID: 15009809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients.
    Satoh S; Thomson AW; Nakamura K; Warty V; Todo S
    Transplantation; 1995 Sep; 60(6):558-62. PubMed ID: 7570951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
    Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
    Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble HLA class II concentrations in normal individuals and transplant recipients. Comparison with soluble HLA class I concentrations.
    McDonald JC; Adamashvili I; Hayes JM; Aultman DF; Rhynes VK; Gelder FB
    Transplantation; 1994 Dec; 58(11):1268-72. PubMed ID: 7992373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of soluble HLA-DR antigens in human serum and other body fluids.
    Hausmann S; Claus R; Buchwald S; Köhler H; Hausmann D; Falk U; Wegener S
    Beitr Infusionsther Transfusionsmed; 1994; 32():281-7. PubMed ID: 9422113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
    Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
    Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA class I in the serum of transplant recipients.
    Rhynes VK; McDonald JC; Gelder FB; Aultman DF; Hayes JM; McMillan RW; Mancini MC
    Ann Surg; 1993 May; 217(5):485-9; discussion 489-91. PubMed ID: 8489311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases.
    Claus R; Bittorf T; Walzel H; Brock J; Uhde R; Meiske D; Schulz U; Hobusch D; Schumacher K; Witt M; Bartel F; Hausmann S
    Cell Immunol; 2000 Dec; 206(2):85-100. PubMed ID: 11161440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
    Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
    Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.